# US 2026/0092276 A1 · Carbohydrate-oligonucleotide conjugates, pharmaceutical compositions, and therapeutic applications

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0092276 A1
- Document ID: US20260092276A1
- Status: Published application
- Kind: A1
- Application number: 19/112,959
- Filed: 2023-09-18
- Published: 2026-04-02
- Earliest claimed: 2022-09-19
- Assignees: Kylonova (Xiamen) Biopharma Co., Ltd.
- Applicants: Kylonova (Xiamen) Biopharma Co., Ltd.
- Inventors: Kunyuan CUI; Xueqin LU
- Web page: https://patentgrep.com/patent/US20260092276A1

## CPC

- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- A61K 47/549: {Sugars, nucleosides, nucleotides or nucleic acids}
- C12N 2310/14: interfering nucleic acids [NA]
- C12N 2310/351: Conjugate
- C12N 2310/51: in polymeric form, e.g. multimers, concatemers
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Carbohydrate-oligonucleotide conjugates are compounds of Formula (I). A pharmaceutical composition comprises the conjugate. The methods of their therapeutic application are treating, preventing, or ameliorating one or more symptoms of a disorder, disease, or condition.

## Claims

### Claim 1

A carbohydrate-oligonucleotide conjugate comprising an ASGPR binding moiety and two oligonucleotides.

### Claim 2 (depends on 1)

The carbohydrate-oligonucleotide conjugate of claim 1, comprising an ASGPR binding moiety, two oligonucleotides, and a trivalent linker.

### Claim 3 (depends on 1, 2)

The carbohydrate-oligonucleotide conjugate of claim 1 or 2, having the structure of Formula (I):
wherein:
R1 is an ASGPR binding moiety;
R2 and R3 are each independently an oligonucleotide;
L1, L2, L3a, and L3c are each independently a linker;
L3b is (i) heteroarylene or heterocyclylene; or (ii) a bond; and
M is (i) N or CH; or (ii) trivalent C1-6 alkyl, trivalent C1-6 heteroalkyl, trivalent C1-6 alkenyl, trivalent C3-10 cycloalkyl, trivalent C6-14 aryl, trivalent heteroaryl, or trivalent heterocyclyl;
wherein each alkyl, heteroalkyl, alkenyl, cycloalkyl, aryl, heteroaryl, heteroarylene, heterocyclyl, or heterocyclylene is optionally substituted with one or more, in one embodiment, one, two, three, or four, substituents Q, wherein each Q is independently selected from: (a) deuterium, cyano, halo, imino, nitro, and oxo; (b) C1-6 alkyl, C1-6 heteroalkyl, C2-6 alkenyl, C2-6 alkynyl, C3-10 cycloalkyl, C6-14 aryl, C7-15 aralkyl, heteroaryl, and heterocyclyl, each of which is further optionally substituted with one or more, in one embodiment, one, two, three, or four, substituents Qa; and (c) —C(O)Ra, —C(O)ORa, —C(O)NRbRc, —C(O)SRa, —C(NRa)NRbRc, —C(S)Ra, —C(S)ORa, —C(S)NRbRc, —ORa, —OC(O)Ra, —OC(O)ORa, —OC(O)NRbRc, —OC(O)SRa, —OC(NRa)NRbRc, —OC(S)Ra, —OC(S)ORa, —OC(S)NRbRc, —OP(O)(ORb)ORc, —OS(O)Ra, —OS(O)2Ra, —OS(O)NRbRc, —OS(O)2NRbRc, —NRbRc, —NRaC(O)Rd, —NRaC(O)ORd, —NRaC(O)NRbRc, —NRaC(O)SRd, —NRaC(NRd)NRbRc, —NRaC(S)Rd, —NRaC(S)ORd, —NRaC(S)NRbRc, —NRaS(O)Rd, —NRaS(O)2Rd, —NRaS(O)NRbRc, —NRaS(O)2NRbRc, —SRa, —S(O)Ra, —S(O)2Ra, —S(O)NRbRc, and —S(O)2NRbRc, wherein each Ra, Rb, Rc, and Rd is independently (i) hydrogen or deuterium; (ii) C1-6 alkyl, C1-6 heteroalkyl, C2-6 alkenyl, C2-6 alkynyl, C3-10 cycloalkyl, C6-14 aryl, C7-15 aralkyl, heteroaryl, or heterocyclyl, each of which is optionally substituted with one or more, in one embodiment, one, two, three, or four, substituents Qa; or (iii) Rb and Rc together with the N atom to which they are attached form heterocyclyl, optionally substituted with one or more, in one embodiment, one, two, three, or four, substituents Qa;
wherein each Qa is independently selected from: (a) deuterium, cyano, halo, nitro, imino, and oxo; (b) C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-10 cycloalkyl, C6-14 aryl, C7-15 aralkyl, heteroaryl, and heterocyclyl; and (c) —C(O)Re, —C(O)ORe, —C(O)NRfRg, —C(O)SRe, —C(NRe)NRfRg, —C(S)Re, —C(S)ORe, —C(S)NRfRg, —ORe, —OC(O)Re, —OC(O)ORe, —OC(O)NRfRg, —OC(O)SRe, —OC(NRe)NRfRg, —OC(S)Re, —OC(S)ORe, —OC(S)NRfRg, —OP(O)(ORf)ORg, —OS(O)Rc, —OS(O)2Rc, —OS(O)NRfRg, —OS(O)2NRfRg, —NRfRg, —NReC(O)Rh, —NReC(O)ORf, —NReC(O)NRfRg, —NReC(O)SRf, —NReC(NRh)NRfRg, —NReC(S)Rh, —NReC(S)ORf, —NReC(S)NRfRg, —NReS(O)Rh, —NReS(O)2Rh, —NReS(O)NRfRg, —NReS(O)2NRfRg, —SRe, —S(O)Re, —S(O)2Re, —S(O)NRfRg, and —S(O)2NRfRg; wherein each Re, Rf, Rg, and Rh is independently (i) hydrogen or deuterium; (ii) C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-10 cycloalkyl, C6-14 aryl, C7-15 aralkyl, heteroaryl, or heterocyclyl; or (iii) Rf and Rg together with the N atom to which they are attached form heterocyclyl.

### Claim 4 (depends on 3)

The carbohydrate-oligonucleotide conjugate of claim 3, wherein L3b is heteroarylene, optionally substituted with one or more substituents Q.

### Claim 5 (depends on 3, 4)

The carbohydrate-oligonucleotide conjugate of claim 3 or 4, wherein L3b is monocyclic heteroarylene, optionally substituted with one or more substituents Q.

### Claim 6 (depends on 3, 4, 5)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 5, wherein L3b is 5-membered heteroarylene, each optionally substituted with one or more substituents Q.

### Claim 7 (depends on 3, 4, 5, 6)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 6, wherein L3b is [1,2,3]triazoldiyl, optionally substituted with one or more substituents Q.

### Claim 8 (depends on 3, 4, 5, 6, 7)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 7, having the structure of Formula (II):

### Claim 9 (depends on 3, 4, 5, 6, 7, 8)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 8, wherein R1 is an ASGPR binding moiety comprising from about 1 to about 10 N-acetylgalactosamines.

### Claim 10 (depends on 3, 4, 5, 6, 7, 8, 9)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 9, wherein R1 is an ASGPR binding moiety comprising about 1, about 2, about 3, about 4, or about 5 N-acetylgalactosamines.

### Claim 11 (depends on 3, 4, 5, 6, 7, 8, 9, 10)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 10, wherein R1 is an ASGPR binding moiety comprising about 2, about 3, or about 4 N-acetylgalactosamines.

### Claim 12 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 11, wherein R1 is an ASGPR binding moiety having the structure of Formula (A-I):
or an enantiomer, a mixture of enantiomers, a diastereomer, a mixture of two or more diastereomers, a tautomer, or a mixture of two or more tautomers thereof; wherein:
Ea and b are:
(i) b is an integer of 2; and Ea is a trivalent linker;
(ii) b is an integer of 1; and Ea is a bond, CH2, or NH; or
(iii) b is an integer of 3; and Ea is a tetravalent linker; and
each La is independently a linker.

### Claim 13 (depends on 12)

The carbohydrate-oligonucleotide conjugate of claim 12, wherein b is an integer of 2; and Ea is a trivalent linker.

### Claim 14 (depends on 12, 13)

The carbohydrate-oligonucleotide conjugate of claim 12 or 13, wherein Ea is CH or N.

### Claim 15 (depends on 12)

The carbohydrate-oligonucleotide conjugate of claim 12, wherein b is an integer of 3 and Ea is a tetravalent linker.

### Claim 16 (depends on 15)

The carbohydrate-oligonucleotide conjugate of claim 15, wherein Ea is C.

### Claim 17 (depends on 12, 13, 14, 15, 16)

The carbohydrate-oligonucleotide conjugate of any one of claims 12 to 16, wherein each La is independently a linker having the structure of —Zn—(Rn Zn)z—, wherein:
each Rn is independently C1-10 alkylene, C2-10 alkenylene, C2-10 alkynylene, C3-10 cycloalkylene, C6-14 arylene, heteroarylene, or heterocyclylene, each optionally substituted with one or more substituents Q;
each Zn is independently a bond, —C(O)—, —C(O)O—, —C(O)NR1b—, —C(O)S—, —C(NR1a)NR1b—, —C(S)—, —C(S)O—, —C(S)NR1b—, —C(R1a)═NO—, —O—, —OC(O)O—, —OC(O)NR1b—, —OC(O)S—, —OC(NR1a)NR1b—, —OC(S)O—, —OC(S)NR1b—, —OS(O)—, —OS(O)2—, —OS(O)NR1b—, —OS(O)2NR1b—, —NR1b—, —NR1aC(O)NR1b—, —NR1aC(O)S—, —NR1aC(NR1d)NR1b—, —NR1aC(S)NR1b, —NR1aS(O)NR1b—, —NR1aS(O)2NR1b—, —P(O2)O)—, —P(O)(S)O—, —S—, —S(O)—, —S(O)2—, —S(O)NR1b—, or —S(O)2NR1b—;
each R1a, R1b, R1c, and R1d is independently (i) hydrogen or deuterium; or (ii) C1-6 alkyl, C1-6 heteroalkyl, C2-6 alkenyl, C2-6 alkynyl, C3-10 cycloalkyl, C6-14 aryl, C7-15 aralkyl, heteroaryl, or heterocyclyl, each optionally substituted with one or more substituents Q; and
z is an integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10.

### Claim 18 (depends on 17)

The carbohydrate-oligonucleotide conjugate of claim 17, wherein each Rn is independently C1-10 alkylene, C6-14 arylene, or heteroarylene, each of which is optionally substituted with one or more substituents Q.

### Claim 19 (depends on 17, 18)

The carbohydrate-oligonucleotide conjugate of claim 17 or 18, wherein each Rn is independently methanediyl, ethanediyl, propanediyl, butanediyl, pentanediyl, hexanediyl, phendiyl, 1,2,3-triazoldiyl, pyrrolidindiyl, or piperidindiyl, each optionally substituted with one, two, or three substituents Q.

### Claim 20 (depends on 17, 18, 19)

The carbohydrate-oligonucleotide conjugate of any one of claims 17 to 19, wherein each Rn is independently methanediyl, ethane-1,2-diyl, propane-1,3-diyl, butane-1,4-diyl, pentane-1,5-diyl, hexane-1,6-diyl, phen-1,4-diyl, 1,2,3-triazol-1,4-diyl, pyrrolidin-1,3-diyl, or piperidin-1,4-diyl, each optionally substituted with one or more substituents Q.

### Claim 21 (depends on 17, 18, 19, 20)

The carbohydrate-oligonucleotide conjugate of any one of claims 17 to 20, wherein each Zn is independently a bond, —C(O)—, —C(O)O—, —C(O)NH—, —OC(O)NH—, —C(CH3)═NO—, —O—, —OP(O2)O—, —OP(O2)S—, —NH—, —N(CH3)—, —S—, or —S(O)2—.

### Claim 22 (depends on 17, 18, 19, 20, 21)

The carbohydrate-oligonucleotide conjugate of any one of claims 17 to 21, wherein each Zn is independently a bond, —C(O)NH—, —O—, —OP(O2)O—, —OP(O2)S—, or —NH—.

### Claim 23 (depends on 17, 18, 19, 20, 21, 22)

The carbohydrate-oligonucleotide conjugate of any one of claims 17 to 22, wherein z is an integer of 0, 1, 2, 3, 4, or 5.

### Claim 24 (depends on 17, 18, 19, 20, 21, 22, 23)

The carbohydrate-oligonucleotide conjugate of any one of claims 17 to 23, wherein each La is independently:

### Claim 25 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 11, wherein the ASGPR binding moiety has the structure of Formula (A-V):
or an enantiomer, a mixture of enantiomers, a diastereomer, a mixture of two or more diastereomers, a tautomer, or a mixture of two or more tautomers thereof; wherein:
Eb and c are:
(i) c is an integer of 2; and Eb is a trivalent linker;
(ii) c is an integer of 1; and Eb is a bond; or
(iii) c is an integer of 3; and Eb is a tetravalent linker;
Ec and d are:
(i) d is an integer of 1; and Ec is bond;
(ii) d is an integer of 2; and Ec is a trivalent linker; or
(iii) d is an integer of 3; and Ec is a tetravalent linker;
G is a trivalent linker; and
each Lb and Lc is independently a divalent linker.

### Claim 26 (depends on 25)

The carbohydrate-oligonucleotide conjugate of claim 25, wherein c is an integer of 2; and Eb is a trivalent linker.

### Claim 27 (depends on 25)

The carbohydrate-oligonucleotide conjugate of claim 25, wherein Eb is

### Claim 28 (depends on 25)

The carbohydrate-oligonucleotide conjugate of claim 25, wherein c is an integer of 1; and Eb is a bond.

### Claim 29 (depends on 25, 26, 27, 28)

The carbohydrate-oligonucleotide conjugate of any one of claims 25 to 28, wherein d is an integer of 2; and Ec is a trivalent linker.

### Claim 30

The carbohydrate-oligonucleotide conjugate of 25 to 29, wherein Ec is

### Claim 31 (depends on 25, 26, 27, 28, 29, 30)

The carbohydrate-oligonucleotide conjugate of any one of claims 25 to 30, wherein each Lb and Lc is independently a linker having the structure of —Zn—(Rn—Zn)z—, wherein:
each Rn is independently C1-10 alkylene, C2-10 alkenylene, C2-10 alkynylene, C3-10 cycloalkylene, C6-14 arylene, heteroarylene, or heterocyclylene, each optionally substituted with one or more substituents;
each Zn is independently a bond, —C(O)—, —C(O)O—, —C(O)NR1b—, —C(O)S—, —C(NR1a)NR1b—, —C(S)—, —C(S)O—, —C(S)NR1b—, —C(R1a)═NO—, —O—, —OC(O)O—, —OC(O)NR1b—, —OC(O)S—, —OC(NR1a)NR1b—, —OC(S)O—, —OC(S)NR1b—, —OS(O)—, —OS(O)2—, —OS(O)NR1b—, —OS(O)2NR1b—, —NR1b—, —NR1aC(O)NR1b—, —NR1aC(O)S—, —NR1aC(NR1d)NR1b—, —NR1aC(S)NR1b—, —NR1aS(O)NR1b—, —NR1aS(O)2NR1b—, —P(O2)O—, —P(O)(S)O—, —S—, —S(O)—, —S(O)2—, —S(O)NR1b, or —S(O)2NR1b—;
each R1a, R1b, R1c, and R1d is independently (i) hydrogen or deuterium; or (ii) C1-6 alkyl, C1-6 heteroalkyl, C2-6 alkenyl, C2-6 alkynyl, C3-10 cycloalkyl, C6-14 aryl, C7-15 aralkyl, heteroaryl, or heterocyclyl, each optionally substituted with one or more substituents; and
z is an integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10.

### Claim 32 (depends on 31)

The carbohydrate-oligonucleotide conjugate of claim 31, wherein each Rn is independently C1-10 alkylene, C6-14 arylene, or heteroarylene, each of which is optionally substituted with one or more substituents Q.

### Claim 33 (depends on 31, 32)

The carbohydrate-oligonucleotide conjugate of claim 31 or 32, wherein each Rn is independently methanediyl, ethanediyl, propanediyl, butanediyl, pentanediyl, hexanediyl, phendiyl, 1,2,3-triazoldiyl, pyrrolidindiyl, or piperidindiyl, each optionally substituted with one, two, or three substituents Q.

### Claim 34 (depends on 31, 32, 33)

The carbohydrate-oligonucleotide conjugate of any one of claims 31 to 33, wherein each Rn is independently methanediyl, ethane-1,2-diyl, propane-1,3-diyl, butane-1,4-diyl, pentane-1,5-diyl, hexane-1,6-diyl, phen-1,4-diyl, 1,2,3-triazol-1,4-diyl, pyrrolidin-1,3-diyl, or piperidin-1,4-diyl, each optionally substituted with one or more substituents Q.

### Claim 35 (depends on 31, 32, 33, 34)

The carbohydrate-oligonucleotide conjugate of any one of claims 31 to 34, wherein each Zn is independently a bond, —C(O)—, —C(O)O)—, —C(O)NH—, —OC(O)NH—, —C(CH3)═NO—, —O—, —OP(O2)O—, —OP(O2)S—, —NH—, —N(CH3)—, —P(O2)O—, —P(O)(S)O—, —S—, or —S(O)2—.

### Claim 36 (depends on 31, 32, 33, 34, 35)

The carbohydrate-oligonucleotide conjugate of any one of claims 31 to 35, wherein each Zn is independently a bond, —C(O)NH—, —O—, —OP(O2)O—, —OP(O2)S—, or —NH—.

### Claim 37 (depends on 31, 32, 33, 34, 35, 36)

The carbohydrate-oligonucleotide conjugate of any one of claims 31 to 36, wherein z is an integer of 0, 1, 2, 3, 4, or 5.

### Claim 38 (depends on 31, 37)

The carbohydrate-oligonucleotide conjugate of claim 31 or 37, wherein each Lb and Lc is independently:

### Claim 39 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 38, wherein R1 is an ASGPR binding moiety having the structure of:

### Claim 40 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 39, wherein R2 is a double-stranded siRNA.

### Claim 41 (depends on 40)

The carbohydrate-oligonucleotide conjugate of claim 40, wherein each strand of the double-stranded siRNA independently comprises from about 10 to about 50, from about 10 to about 30, or from about 15 to about 25 nucleotides.

### Claim 42 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 39, wherein R2 is a single-stranded oligonucleotide.

### Claim 43 (depends on 42)

The carbohydrate-oligonucleotide conjugate of claim 42, wherein R2 is a single-stranded oligodeoxyribonucleotide.

### Claim 44 (depends on 42, 43)

The carbohydrate-oligonucleotide conjugate of claim 42 or 43, wherein the single-stranded oligonucleotide comprises from about 10 to about 50, from about 10 to about 30, or from about 15 to about 25 nucleotides.

### Claim 45 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 44, wherein R3 is a double-stranded siRNA.

### Claim 46 (depends on 45)

The carbohydrate-oligonucleotide conjugate of claim 45, wherein each strand of the double-stranded siRNA independently comprises from about 10 to about 50, from about 10 to about 30, or from about 15 to about 25 nucleotides.

### Claim 47 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 44, wherein R3 is a single-stranded oligonucleotide.

### Claim 48 (depends on 47)

The carbohydrate-oligonucleotide conjugate of claim 47, wherein R3 is a single-stranded oligodeoxyribonucleotide.

### Claim 49 (depends on 47, 48)

The carbohydrate-oligonucleotide conjugate of claim 47 or 48, wherein the single-stranded oligonucleotide comprises from about 10 to about 50, from about 10 to about 30, or from about 15 to about 25 nucleotides.

### Claim 50 (depends on 41, 44, 46)

The carbohydrate-oligonucleotide conjugate of any one of claims 41, 44, 46, and 49, wherein each nucleotide is independently a natural nucleotide or modified nucleotide.

### Claim 51 (depends on 41, 44, 46, 49)

The carbohydrate-oligonucleotide conjugate of any one of claims 41, 44, 46, 49, and 50, wherein each nucleotide is independently adenylate, cytidylate, guanylate, uridylate, 2′-fluoroadenosine, 2′-fluorocytidine, 2′-fluorogunaosine, 2′-fluorouridine, 2′-deoxyadenosine, 2′-deoxycytidine, 2′-deoxygunaosine, 2′-deoxythymidine, 2′-O-methyladenosine, 2′-O-methyl-cytidine, 2′-O-methylguanosine, or 2′-O-methyluridine.

### Claim 52 (depends on 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51)

The carbohydrate-oligonucleotide conjugate of any one of claims 41 to 51, wherein each strand has one or more phosphate linkage groups each independently replaced with phosphorothioate or phosphorodithiate.

### Claim 53 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 45, 46, 47, 48, 49, 50, 51, 52)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 41 and 45 to 52, wherein R2 is a double-stranded siRNA comprising a pair of nucleotide sequences of SEQ ID NOs: 1 and 2, 3 and 4, 5 and 6, 7 and 8, 9 and 10, 11 and 12, 13 and 14, 15 and 16, 17 and 18, 19 and 20, 21 and 22, or 23 and 24.

### Claim 54 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 45, 46, 47, 48, 49, 50, 51, 52, 53)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 41 and 45 to 53, wherein R2 is a double-stranded siRNA comprising a pair of nucleotide sequences of SEQ ID NOs: 1 and 2, 3 and 4, 5 and 6, 9 and 10, 13 and 14, 15 and 16, 19 and 20, or 23 and 24.

### Claim 55 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 50, 51, 52, 53, 54)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 46 and 50 to 54, wherein R3 is a double-stranded siRNA comprising a pair of nucleotide sequences of SEQ ID NOs: 1 and 2, 3 and 4, 5 and 6, 7 and 8, 9 and 10, 11 and 12, 13 and 14, 15 and 16, 17 and 18, 19 and 20, 21 and 22, or 23 and 24.

### Claim 56 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 50, 51, 52, 53, 54, 55)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 46 and 50 to 55, wherein R3 is a double-stranded siRNA comprising a pair of nucleotide sequences of SEQ ID NOs: 1 and 2, 3 and 4, 7 and 8, 11 and 12, 17 and 18, 19 and 20, or 21 and 22.

### Claim 57 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 44 and 47 to 56, wherein R3 is a single-stranded oligonucleotide comprising the nucleotide sequence of SEQ ID NO: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, or 25.

### Claim 58 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 57, wherein L1, L2, L3a, and L3c are each independently a linker having the structure of —Zn—(Rn—Zn)z—, wherein:
each Rn is independently C1-10 alkylene, C2-10 alkenylene, C2-10 alkynylene, C3-10 cycloalkylene, C6-14 arylene, heteroarylene, or heterocyclylene, each optionally substituted with one or more substituents;
each Zn is independently a bond, —C(O)—, —C(O)O—, —C(O)NR1b—, —C(O)S—, —C(NR1a)NR1b—, —C(S)—, —C(S)O—, —C(S)NR1b—, —C(R1a)═NO—, —O—, —OC(O)O—, —OC(O)NR1b—, —OC(O)S—, —OC(NR1a)NR1b—, —OC(S)O—, —OC(S)NR1b—, —OS(O)—, —OS(O)2—, —OS(O)NR1b—, —OS(O)2NR1b—, —NR1b—, —NR1aC(O)NR1b, —NR1aC(O)S—, —NR1aC(NR1d)NR1b—, —NR1aC(S)NR1b—, —NR1aS(O)NR1b—, —NR1aS(O)—NR1b—, —P(O2)O—, —P(O)(S)O—, —S—, —S(O)—, —S(O)2—, —S(O)NR1b—, or —S(O)2NR1b—;
each R1a, R1b, R1c, and R1d is independently (i) hydrogen or deuterium; or (ii) C1-6 alkyl, C1-6 heteroalkyl, C2-6 alkenyl, C2-6 alkynyl, C3-10 cycloalkyl, C6-14 aryl, C7-15 aralkyl, heteroaryl, or heterocyclyl, each optionally substituted with one or more substituents; and
z is an integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10.

### Claim 59 (depends on 58)

The carbohydrate-oligonucleotide conjugate of claim 58, wherein each Rn is independently C1-10 alkylene, C6-14 arylene, or heteroarylene, each of which is optionally substituted with one or more substituents Q.

### Claim 60 (depends on 58, 59)

The carbohydrate-oligonucleotide conjugate of claim 58 or 59, wherein each Rn is independently methanediyl, ethanediyl, propanediyl, butanediyl, pentanediyl, hexanediyl, phendiyl, 1,2,3-triazoldiyl, or pyrrolidindiyl, each optionally substituted with one, two, or three substituents Q.

### Claim 61 (depends on 58, 59, 60)

The carbohydrate-oligonucleotide conjugate of any one of claims 58 to 60, wherein each Rn is independently methanediyl, ethane-1,2-diyl, propane-1,3-diyl, butane-1,4-diyl, pentane-1,5-diyl, hexane-1,6-diyl, phen-1,4-diyl, 1,2,3-triazol-1,4-diyl, or pyrrolidin-1,3-diyl, each optionally substituted with one or more substituents Q.

### Claim 62 (depends on 58, 59, 60, 61)

The carbohydrate-oligonucleotide conjugate of any one of claims 58 to 61, wherein each Zn is independently a bond, —C(O)—, —C(O)O—, —C(O)NH—, —OC(O)NH—, —C(CH3)═NO—, —O—, —OP(O2)O—, —OP(O2)S—, —NH—, —N(CH3)—, —P(O2)O)—, —P(O2)S—, —S—, or —S(O)2—.

### Claim 63 (depends on 58, 59, 60, 61, 62)

The carbohydrate-oligonucleotide conjugate of any one of claims 58 to 62, wherein each Zn is independently a bond, —C(O)NH—, —O—, —OP(O2)O—, —OP(O2)S—, —NH—, —P(O2)O—, or —P(O2)S—.

### Claim 64 (depends on 58, 59, 60, 61, 62, 63)

The carbohydrate-oligonucleotide conjugate of any one of claims 58 to 63, wherein z is an integer of 0, 1, 2, 3, 4, or 5.

### Claim 65 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 64, wherein L1 is —NHC(O)(CH2)eC(O)NH—, wherein e is an integer of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, or 15.

### Claim 66 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 65, wherein L1 is

### Claim 67 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 66, wherein L2 has the structure of —X(CH2)hX—; each X is independently —O—, —S—, or —N(H)—; and h is an integer of 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12.

### Claim 68 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 66, wherein L2 has the structure of —X(CH2)iCH(OH)(CH2)jX—; each X is independently —O—, —S—, or —N(H)—; and i and j are each independently an integer of 2, 3, 4, 5, 6, 7, 8, 9, or 10.

### Claim 69 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 66, wherein L2 has the structure of
and L2 is attached to a 5′-terminus of an oligonucleotide.

### Claim 70 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 66, wherein L2 has the structure of
and L2 is attached to a 3′-terminus of an oligonucleotide.

### Claim 71 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 66, wherein L2 is:

### Claim 72 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 71, wherein L3a is —CH2—, —CH2CH2—, —CH2CH2CH2—, —CH2CH2CH2CH2—,

### Claim 73 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 72, wherein L3c has the structure of —X(CH2)pX—; each X is independently —O—, —S—, or —N(H)—; and p is an integer of 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12.

### Claim 74 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 72, wherein L3c has the structure of —X(CH2)qCH(OH)(CH2)pX—; each X is independently —O—, —S—, or —N(H)—; and q and r are each independently an integer of 2, 3, 4, 5, 6, 7, 8, 9, or 10.

### Claim 75 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 72, wherein L3c has the structure of
and L2 is attached to a 5′-terminus of an oligonucleotide.

### Claim 76 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 72, wherein L3c has the structure of
and L2 is attached to a 3′-terminus of an oligonucleotide.

### Claim 77 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 72, wherein L3c is

### Claim 78 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 77, wherein M is N, CH, or C(CH3).

### Claim 79 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78)

The carbohydrate-oligonucleotide conjugate of any one of claims 3 to 78, wherein the trivalent moiety
has the structure of:

### Claim 80 (depends on 1, 2, 3)

The carbohydrate-oligonucleotide conjugate of any one of claims 1 to 3, having the structure of:
wherein each 3′-siRNA independently represents a siRNA with one of its 3′-termini connected to a trivalent linker; each 5′-siRNA represents a siRNA with one of its 5′-termini connected to a trivalent linker; and 5′-ssDNA represents a single stranded DNA with its 5′-terminus connected to a trivalent linker.

### Claim 81 (depends on 1)

The carbohydrate-oligonucleotide conjugate of claim 1, having the structure of:
wherein 3′-siRNA represents a siRNA with one of its 3′-termini connected to a first divalent linker and one of its 5′-termini connected to a second divalent linker; and 5′-siRNA represents a siRNA with one of its 5′-termini connected to the second divalent linker.

### Claim 82 (depends on 80, 81)

The carbohydrate-oligonucleotide conjugate of claim 80 or 81, wherein each double-stranded oligonucleotide independently comprises a pair of nucleotide sequences of SEQ ID NOs: 1 and 2, 3 and 4, 5 and 6, 7 and 8, 9 and 10, 11 and 12, 13 and 14, 15 and 16, 17 and 18, 19 and 20, 21 and 22, or 23 and 24.

### Claim 83 (depends on 80)

The carbohydrate-oligonucleotide conjugate of claim 80, wherein each single-stranded oligonucleotide comprises a nucleotide sequence of SEQ ID NO: 25.

### Claim 84 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83)

A pharmaceutical composition comprising the carbohydrate-oligonucleotide conjugate of any one of claims 1 to 83 and a pharmaceutically acceptable excipient.

### Claim 85 (depends on 84)

The pharmaceutical composition of claim 84, wherein the composition is in single dosage form.

### Claim 86 (depends on 84, 85)

The pharmaceutical composition of claim 84 or 85, wherein the composition is in a parenteral or intravenous dosage form.

### Claim 87 (depends on 86)

The pharmaceutical composition of claim 86, wherein the composition is formulated in an intravenous dosage form.
